Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00362973
First received: August 10, 2006
Last updated: May 15, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)